[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
[ Tue, Apr 26th 2022 ]: WOPRAI
Patrick O"Shaughnessy Maintained (CBRE) at Buy with Decreased Target to $111 on, Apr 26th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Patrick O"Shaughnessy of Raymond James, Maintained "CBRE Group, Inc." (CBRE) at Buy with Decreased Target from $126 to $111 on, Apr 26th, 2022.
Patrick has made no other calls on CBRE in the last 4 months.
There is 1 other peer that has a rating on CBRE. Out of the 1 peers that are also analyzing CBRE, 0 agree with Patrick"s Rating of Hold.
This is the rating of the analyst that currently disagrees with Patrick;
Andrew Rosivach of "Wolfe Research" Maintained at Buy with Decreased Target to $116 on, Thursday, March 10th, 2022